{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:26:45Z","timestamp":1790130405909,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["2617H04338"],"award-info":[{"award-number":["2617H04338"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.canlet.2018.10.027","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T16:03:52Z","timestamp":1540569832000},"page":"181-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination"],"prefix":"10.1016","volume":"442","author":[{"given":"Yang","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Fujikake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Senga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyosumi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.10.027_bib1","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2018.10.027_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3322\/caac.21392","article-title":"Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening","volume":"67","author":"Smith","year":"2017","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.canlet.2018.10.027_bib3","series-title":"The Peritoneal \"soil\" for a Cancerous \"seed\": a Comprehensive Review of the Pathogenesis of Intraperitoneal Cancer Metastases, Cellular and Molecular Life Sciences","author":"Mikula-Pietrasik","year":"2017"},{"key":"10.1016\/j.canlet.2018.10.027_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","article-title":"Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition","volume":"33","author":"Thibault","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2018.10.027_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/path.4002","article-title":"The peritoneal tumour microenvironment of high-grade serous ovarian cancer","volume":"227","author":"Leinster","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2018.10.027_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0014-5793(99)01400-3","article-title":"Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells","volume":"460","author":"Hong","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2018.10.027_bib7","doi-asserted-by":"crossref","first-page":"35462","DOI":"10.1074\/jbc.M110.109579","article-title":"Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis","volume":"285","author":"Shahzad","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2018.10.027_bib8","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1038\/oncsis.2014.33","article-title":"Targeting filamin B induces tumor growth and metastasis via enhanced activity of matrix metalloproteinase-9 and secretion of VEGF-A","volume":"3","author":"Bandaru","year":"2014","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2018.10.027_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2018.10.027_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.417","article-title":"Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases","volume":"7","author":"Mikula-Pietrasik","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2018.10.027_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.canlet.2014.09.041","article-title":"Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo","volume":"355","author":"Mikula-Pietrasik","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2018.10.027_bib12","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","article-title":"Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion","volume":"124","author":"Kenny","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2018.10.027_bib13","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2013.321","article-title":"Epithelial ovarian cancer experimental models","volume":"33","author":"Lengyel","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.10.027_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2015.08.010","article-title":"Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum","volume":"139","author":"Nakamura","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2018.10.027_bib15","first-page":"E950","article-title":"Estradiol-mediated hepatocyte growth factor is involved in the implantation of endometriotic cells via the mesothelial-to-mesenchymal transition in the peritoneum, American journal of physiology","volume":"308","author":"Ono","year":"2015","journal-title":"Endocrinology and metabolism"},{"key":"10.1016\/j.canlet.2018.10.027_bib16","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1172\/JCI69815","article-title":"Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance","volume":"124","author":"Davidowitz","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2018.10.027_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/path.4695","article-title":"Mesothelial-to-mesenchymal transition in the pathogenesis of post-surgical peritoneal adhesions","volume":"239","author":"Sandoval","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2018.10.027_bib18","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/0008-5472.CAN-05-1292","article-title":"Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells","volume":"66","author":"Ren","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.10.027_bib19","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1101\/gad.279737.116","article-title":"Carcinoma-associated fibroblasts: orchestrating the composition of malignancy","volume":"30","author":"Gascard","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2018.10.027_bib20","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3390\/cancers7040872","article-title":"The mesothelial origin of carcinoma associated-fibroblasts in peritoneal metastasis","volume":"7","author":"Rynne-Vidal","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2018.10.027_bib21","first-page":"193","article-title":"A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-beta derived from ovarian cancer","volume":"39","author":"Fujikake","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2018.10.027_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0092-8674(90)90009-4","article-title":"Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene","volume":"62","author":"Montesano","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2018.10.027_bib23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.coph.2013.05.014","article-title":"The plasminogen activation system: new targets in lung inflammation and remodeling","volume":"13","author":"Schuliga","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.canlet.2018.10.027_bib24","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","article-title":"Plasminogen-activator inhibitor type 1 and coronary artery disease","volume":"342","author":"Kohler","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2018.10.027_bib25","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1007\/s11095-010-0219-2","article-title":"Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells","volume":"27","author":"Ramer","year":"2010","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.canlet.2018.10.027_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2017.02.025","article-title":"Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma","volume":"394","author":"Liu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2018.10.027_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/94.2.116","article-title":"Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients","volume":"94","author":"Look","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2018.10.027_bib28","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/jnci\/djs377","article-title":"Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function","volume":"104","author":"Fang","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2018.10.027_bib29","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1038\/s41598-017-05620-6","article-title":"Novel intraperitoneal treatment with non-thermal plasma-activated medium inhibits metastatic potential of ovarian cancer cells","volume":"7","author":"Nakamura","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2018.10.027_bib30","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1158\/1535-7163.MCT-14-0135","article-title":"Expression of the miR200 family of microRNAs in mesothelial cells suppresses the dissemination of ovarian cancer cells","volume":"13","author":"Sugiyama","year":"2014","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.canlet.2018.10.027_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4281","article-title":"Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis","volume":"231","author":"Sandoval","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2018.10.027_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2016.03.036","article-title":"Tumor-associated macrophage-derived CXCL8 could induce ERalpha suppression via HOXB13 in endometrial cancer","volume":"376","author":"Tong","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2018.10.027_bib33","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1158\/0008-5472.CAN-04-1272","article-title":"Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer","volume":"64","author":"Curiel","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.10.027_bib34","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1158\/0008-5472.CAN-09-4341","article-title":"Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy","volume":"70","author":"Agarwal","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2018.10.027_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12032-016-0810-4","article-title":"Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors","volume":"33","author":"Mikula-Pietrasik","year":"2016","journal-title":"Med. Oncol. (Lond.)"},{"key":"10.1016\/j.canlet.2018.10.027_bib36","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1158\/1940-6207.CAPR-13-0227","article-title":"The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis","volume":"6","author":"Cohen","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.canlet.2018.10.027_bib37","doi-asserted-by":"crossref","first-page":"30353","DOI":"10.1074\/jbc.274.43.30353","article-title":"IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain","volume":"274","author":"Sakurai","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2018.10.027_bib38","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1074\/jbc.M113.502641","article-title":"Proteasome inhibition increases recruitment of IkappaB kinase beta (IKKbeta), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 production in ovarian cancer cells","volume":"289","author":"Singha","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2018.10.027_bib39","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1038\/onc.2015.43","article-title":"Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis","volume":"34","author":"Mitra","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2018.10.027_bib40","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.biocel.2009.01.015","article-title":"Revisiting the seed and soil in cancer metastasis","volume":"41","author":"Mendoza","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2018.10.027_bib41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1349-7006.2011.02195.x","article-title":"Behavior of seeds and soil in the mechanism of metastasis: a deeper understanding","volume":"103","author":"Mathot","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2018.10.027_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2016.04.038","article-title":"Tumor microenvironment: the culprit for ovarian cancer metastasis?","volume":"377","author":"Luo","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2018.10.027_bib43","first-page":"566","article-title":"Profiling of cytokines in human epithelial ovarian cancer ascites","volume":"2","author":"Matte","year":"2012","journal-title":"American journal of cancer research"},{"key":"10.1016\/j.canlet.2018.10.027_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ijc.29385","article-title":"Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms","volume":"137","author":"Matte","year":"2015","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2018.10.027_bib45","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.10.027_bib46","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1038\/ncomms14470","article-title":"Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer","volume":"8","author":"Yokoi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2018.10.027_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/15384047.2014.1001271","article-title":"Inhibition of plasminogen activator inhibitor-1 is a potential therapeutic strategy in ovarian cancer","volume":"16","author":"Mashiko","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2018.10.027_bib48","first-page":"1108","article-title":"Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites","volume":"8","author":"Milliken","year":"2002","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.canlet.2018.10.027_bib49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cyto.2012.04.020","article-title":"Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells","volume":"59","author":"Wang","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.canlet.2018.10.027_bib50","doi-asserted-by":"crossref","first-page":"42262","DOI":"10.18632\/oncotarget.15040","article-title":"Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2018.10.027_bib51","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1200\/JCO.2005.02.047","article-title":"Role of transforming growth factor Beta in human cancer","volume":"23","author":"Elliott","year":"2005","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.canlet.2018.10.027_bib52","doi-asserted-by":"crossref","first-page":"22595","DOI":"10.1074\/jbc.M313004200","article-title":"The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1","volume":"279","author":"Degryse","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2018.10.027_bib53","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/jth.13869","article-title":"Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin","volume":"15","author":"Luo","year":"2017","journal-title":"J. Thromb. Haemostasis : JTH"},{"key":"10.1016\/j.canlet.2018.10.027_bib54","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.ATV.0000227514.50065.2a","article-title":"Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1","volume":"26","author":"Chen","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.canlet.2018.10.027_bib55","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.4049\/jimmunol.1004088","article-title":"The protein kinase IKKepsilon is a potential target for the treatment of inflammatory hyperalgesia","volume":"187","author":"Moser","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2018.10.027_bib56","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/26261","article-title":"IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex","volume":"395","author":"Rothwarf","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.10.027_bib57","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/jog.12474","article-title":"Variation and prognostic value of serum plasminogen activator inhibitor-1 before and after chemotherapy in patients with epithelial ovarian cancer","volume":"40","author":"Chen","year":"2014","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.canlet.2018.10.027_bib58","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.humpath.2014.07.003","article-title":"ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder","volume":"45","author":"Faraj","year":"2014","journal-title":"Hum. Pathol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518306414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T04:17:11Z","timestamp":1605327431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518306414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":58,"alternative-id":["S0304383518306414"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.10.027","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}